| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |